Upadacitinib and Pain in RA, PsA - Quiz - MDSpire

Upadacitinib and Pain in RA, PsA

Mediation analysis suggests direct and indirect effects on pain reduction in rheumatoid and psoriatic arthritis.

  • By

  • Kathryn Wighton

  • February 25, 2026

  • 4 min

Share

Original Source(s)

Upadacitinib and Pain in RA, PsA

  • by Kathryn Wighton

  • February 25, 2026

Related Content

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

Migraine with comorbid fibromyalgia: psychological burden and impact on frequency and severity of migraine attacks

Deep Remission Tied to RA Control

At 5 years, 63% of patients in the CliDR group maintained sustained remission compared with 38% in the non-CliDR group.